Live Breaking News & Updates on குறி சர்டி

Stay updated with breaking news from குறி சர்டி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Piet Viljoen on Ascendis, Transaction Capital and his own portfolio


Piet Viljoen on Ascendis, Transaction Capital and his own portfolio
Piet Viljoen, fund manager of the Counterpoint Value Fund, joined the BizNews Power Hour as co-host. Viljoen, who has both Ascendis and Transaction Capital in his portfolio, weighed in on the recent developments with both companies. K
nown to many as one of the last purists out there in respect of value investing, Viljoen applied his keen understanding to a host of topics, including Naspers and Prosus as well as which clues an investor should look out for to see whether or not management is overreaching. – Nadya Swart
Piet Viljoen on the view that Ascendis CEO Mark Sardi made it possible for shareholders to get something out when they might have got nothing: ....

South Africa , South African , Nadya Swart , Piet Viljoen , Mark Sardi , Counterpoint Value Fund , Biznews Power Hour , Transaction Capital , Biznews Power Hour , Piet Viljoen , Transaction Capital , Value Investing , Usiness News , South Africa , நாடிய ஸ்வர்ட் , குறி சர்டி , எதிர் புள்ளி மதிப்பு நிதி , பரிவர்த்தனை மூலதனம் ,

Ascendis Health forges a deal with its lenders to settle R7.61bn debt


Ascendis Health forges a deal with its lenders to settle R7.61bn debt
By Sandile Mchunu
Share
DURBAN - ASCENDIS Health yesterday reached an agreement with its lenders for the restructuring and recapitalisation agreement with its creditors Blantyre Capital and L1 Health for the settlement of its outstanding debt of €447 million (R7.61 billion).
However, the group said the proposed transaction required 75 percent of shareholder approval, adding that if it did not receive the required shareholder support, the senior lenders would be able to enforce their rights and Ascendis Health would be placed in business rescue.
The agreement comes after Blantyre Capital and L1 Health increased their exposure to the company s debt to more than 75 percent of the aggregate exposure of the company s consortium of external lenders in February. ....

South Africa , Kwazulu Natal , South African , Mark Sardi , Ascendis Health European , Ascendis Health South African , Animal Health , Ascendis Health , Blantyre Capital , South African Based , Cyprus Based Remedica , Sun Wave Pharma , Respiratory Care Africa , Medical Devices , Consumer Brands , க்வஸூல்யூ நேட்டல் , குறி சர்டி , விலங்கு ஆரோக்கியம் , ப்ளாண்ட்யரே மூலதனம் , சூரியன் அலை பார்மா , மருத்துவ சாதனங்கள் , நுகர்வோர் பிராண்டுகள் ,